| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Suitable for: | Elderly, Adult |
| Purity: | >99% |
| Transport Package: | Drum or as Required |
| Specification: | Customized |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Product details
| Supply CAS 9001-01-8 Proteolytic Enzyme Kallidinogenase Kallikrein Powder | ||||
|
Product Name
|
Kallidinogenase
|
|||
|
Odor
|
Characteristic
|
|||
|
Particle size
|
100% pass through 80 mesh sieve
|
|||
|
Heavy metals(as Pb)
|
<10ppm
|
|||
|
Arsenic(as AS2O3)
|
<2ppm
|
|||
|
Total bacterial count
|
Max.1000cfu/g
|
|||
|
Yeast & Mould
|
Max.100cfu /g
|
|||
|
Escherichia coli presence
|
Negative
|
|||
|
Salmonella
|
Negative
|
|||
|
Test Items
|
CP
|
JP
|
|
Characters
|
White or almost white powder, odourless
|
White to slighty brown powder, odourless or has a faint
|
|
ldentification
|
R(hydrolysis rate): 0.12~0.17
|
R (hydrolysis rate): 0.12~0.16
|
|
Liquid Chromatography: Conforms
|
l :≤0.2
|
|
|
Fat
|
≤ 5.0mg/g
|
/
|
|
PH
|
5.5~7.5 ( 300unit/ml )
|
/
|
|
Kininase
|
/
|
R value : ≥0.8
|
|
Trypsin-like substance
|
/
|
T value: s0.05
|
|
Protease
|
A280≤ 0.2
|
A280≤ 0.2
|
|
Loss on drying
|
≤5.0% (60ºC Dry in Vacuum,4h)
|
≤2.0% (60ºC Dry in Vacuum,4h)
|
|
Residue on ignition
|
≤ 3.0%
|
≤ 3.0%
|
|
Kinin-releasing activity
|
/
|
≥ 500ng bradykinin equivalentmin/unit per unit
|
|
Purity
|
≥75% (for oral)
≥90%(for injection)
|
/
|
|
Bacterial endotoxin
|
≤2.5 EU/unit (for injection)
|
/
|
|
Enzyme activity
|
/
|
≥ 25 unit/mg
|
|
Specific activity
|
≥ 300 unit/mg protein (for oral)
≥ 600 unit/mg protein (for injection)
|
≥100 unit/mg protein
|
|
TAMC
|
≤ 1000cfu/g (for oral)
≤ 100cfu/g (for injection)
|
≤ 1000cfu/g
|
|
TYMC
|
≤ 100cfu/g
|
≤ 100cfu/g
|
|
E. coli
|
Conforms
|
Conforms
|
|
Salmonella
|
Conforms
|
Conforms
|
|
Specification
|
According to CP 2015 and current JP
|
|
Product Name
|
CAS NO.
|
Purity
|
|
Nepafenac
|
78281-72-8
|
99%
|
|
Nisoldipine
|
63675-72-9
|
99%
|
|
Manidipine Dihydrochloride
|
89226-75-5
|
99%
|
|
Cilnidipine
|
132203-70-4
|
99%
|
|
Nitrendipine
|
39562-70-4
|
99%
|
|
Felodipine
|
72509-76-3
|
99%
|
|
Pranidipine
|
99522-79-9
|
99%
|
|
Benidipine
|
105979-17-7
|
99%
|
|
Mitiglinide Calcium Hydrate
|
145525-41-3
|
99%
|
|
Bromfenac sodium
|
91714-93-1
|
99%
|
|
Loteprednol etabonate
|
129260-79-3
|
99%
|
|
Esmolo Hydrochloride
|
81161-17-3
|
99%
|
|
Clofarabine
|
123318-82-1
|
99%
|
|
strontium ranelate
|
135459-87-9
|
99%
|
|
Clevidipine
|
166432-28-6
|
99%
|
This product can be used for a variety of cardiovascular and cerebovascular disease, such as coronary heart disease, cerebral arteriosclerosis, cerebral thrombosis, retinal blood supply disorders and peripheral vascular disease. Have a better therapeutic effect on recent researches for thr prevention of early diabetic microangiopathy and diabetic nephropathy, can reduce the albumin excretion. Clinical data both at home and abroad suggest that it can increase sperm activity and production quantity, and has certain curative effect in the treatment of some male sterility.
MAIN SUPPLY
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}